S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
NASDAQ:IPSC

Century Therapeutics News Headlines

$16.06
+0.35 (+2.23%)
(As of 12/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$15.86
$16.97
50-Day Range
$15.23
$25.16
52-Week Range
$14.14
$32.90
Volume
60,870 shs
Average Volume
175,593 shs
Market Capitalization
$877.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Media Mentions By Week



Century Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IPSC
News Sentiment

-0.16

0.34

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IPSC Articles
This Week

5

1

IPSC Articles
Average Week

Get Century Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IPSC and its competitors with MarketBeat's FREE daily newsletter.

Century Therapeutics (NASDAQ:IPSC) News Headlines Today

SourceHeadline
MarketBeat logoCentury Therapeutics (NASDAQ:IPSC) Sets New 52-Week Low at $14.34
americanbankingnews.com - December 6 at 12:01 PM
MarketBeat logoCentury Therapeutics (NASDAQ:IPSC) Shares Gap Up to $16.49
americanbankingnews.com - December 2 at 12:08 PM
MarketBeat logoCentury Therapeutics (NASDAQ:IPSC) Shares Gap Down to $19.11
americanbankingnews.com - December 1 at 12:06 PM
MarketBeat logoCentury Therapeutics (NASDAQ:IPSC) Shares Gap Down to $17.71
americanbankingnews.com - November 24 at 10:58 AM
finance.yahoo.com logoCentury Therapeutics to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
finance.yahoo.com - November 22 at 12:41 PM
MarketBeat logoCentury Therapeutics (NASDAQ:IPSC) Shares Down 6.9% Following Analyst Downgrade
americanbankingnews.com - November 22 at 11:20 AM
MarketBeat logoMesoblast (NASDAQ:MESO) versus Century Therapeutics (NASDAQ:IPSC) Financial Analysis
americanbankingnews.com - November 21 at 11:06 AM
MarketBeat logoSVB Leerink Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $32.00
americanbankingnews.com - November 19 at 11:22 AM
MarketBeat logoCentury Therapeutics (NASDAQ:IPSC) Shares Gap Up to $20.95
americanbankingnews.com - November 19 at 10:34 AM
MarketBeat logoCentury Therapeutics (NASDAQ:IPSC) Sees Large Volume Increase
americanbankingnews.com - November 18 at 12:01 PM
MarketBeat logoCentury Therapeutics, Inc. (NASDAQ:IPSC) Forecasted to Earn FY2021 Earnings of ($5.29) Per Share
americanbankingnews.com - November 15 at 1:56 AM
finance.yahoo.com logoCentury Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates
finance.yahoo.com - November 10 at 10:35 AM
finance.yahoo.com logoCentury Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Host Virtual Research & Development Update
finance.yahoo.com - November 4 at 1:05 PM
nasdaq.com logoCentury Therapeutics Inc Shares Fall 6.7% Below Previous 52-Week Low - Market Mover
nasdaq.com - October 12 at 10:13 AM
finance.yahoo.com logoCentury Therapeutics Announces Its Addition to the Russell 2000® Index
finance.yahoo.com - September 17 at 6:49 PM
au.finance.yahoo.com logoGlobal $4.54 Bn Induced Pluripotent Stem Cell (iPSC) Markets, 2021-2025 & 2030
au.finance.yahoo.com - September 15 at 7:54 PM
finance.yahoo.com logoCentury Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates
finance.yahoo.com - August 12 at 4:04 PM
markets.businessinsider.com logoThese 3 New Biotechs Have Differentiated Platforms, Technology: BofA
markets.businessinsider.com - July 13 at 9:01 PM
nasdaq.com logoCentury Therapeutics Rings The Nasdaq Stock Market Closing Bell
nasdaq.com - June 24 at 9:11 AM
nasdaq.com logoCentury Therapeutics Rings The Closing Bell
nasdaq.com - June 23 at 6:48 PM
finance.yahoo.com logoCentury Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 23 at 8:47 AM
Get Century Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IPSC and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.